How to Inject Peptides: Full Guide

Before gathering supplies or choosing a site, this table gives you the core parameters for both injection routes. Print it or screenshot it for your first session.

The default for 95% of peptide users is subcutaneous. Intramuscular injection is reserved for specific situations covered in the IM section below. If you are unsure which route to use, choose subcutaneous into the abdominal fat pad.

Gather every item before you uncap a syringe. Searching for an alcohol swab while holding a loaded needle is how contamination happens.

Syringe sizing matters for accuracy. A 0.5mL syringe (50 units) has wider tick-mark spacing than a 1mL syringe (100 units). If your dose is 10 units, a 2-unit reading error on a 0.5mL syringe is a 20% dosing error. On a 1mL syringe with tighter markings, the same misread becomes more likely. Use the smaller syringe for doses under 25 units. Use the peptide unit converter to translate milligrams into syringe units based on your reconstitution volume.

Do not buy: pre-loaded syringes from unverified sources, reusable needles, needles thicker than 25 gauge, or glass syringes. Peptide solutions are water-based and flow easily through fine needles. Thick-gauge needles designed for viscous oil-based compounds cause unnecessary pain and bruising.

For guidance on evaluating peptide suppliers and reading certificates of analysis, see the peptide safety guide. For sourcing in 2026, see where to buy peptides.

Most research peptides ship as white, freeze-dried powder inside a sealed glass vial. You cannot inject powder. Reconstitution converts the lyophilized cake into an injectable liquid. The process takes under 3 minutes and determines every dose you draw for the next 30 days.

Step-by-step reconstitution:

1. 1.Remove the plastic flip cap from the peptide vial to expose the rubber stopper.
2. 2.Swab the stopper with a 70% isopropyl alcohol pad. Let it air dry for 10 seconds.
3. 3.Draw your chosen volume of bacteriostatic water into a syringe. Common reconstitution volumes are 1mL or 2mL depending on the peptide and desired concentration.
4. 4.Insert the needle through the rubber stopper. Aim the tip at the glass wall inside the vial, not directly at the powder.
5. 5.Push the water slowly down the inside wall. Think of it like pouring beer against the side of a glass to avoid foam. Direct spray onto the powder can shear peptide bonds through mechanical force.
6. 6.Withdraw the syringe. Gently swirl the vial in small circles until the powder dissolves completely. This takes 30 to 60 seconds. Never shake. Aggressive shaking causes agitation-induced aggregation, denaturing the peptide and reducing potency (Manning et al., Pharm Res, 2010).
7. 7.Label the vial with today's date, the peptide name, and the concentration (e.g., "BPC-157, 5mg/2mL = 2500mcg/mL, reconstituted 3/16/26").
8. 8.Refrigerate immediately at 2 to 8 degrees Celsius.

Use bacteriostatic water, not sterile water. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits microbial growth and keeps the vial safe for multi-dose use over 28 to 30 days. Sterile water has no preservative. Bacteria can colonize a sterile-water vial within 24 to 48 hours of the first needle puncture (Mulloy & Bhatt, USP Microbiology, 2012). By day 5, you may be injecting contaminated liquid.

For peptide-specific reconstitution instructions, see how to reconstitute tirzepatide, how to reconstitute GHK-Cu, and how to reconstitute retatrutide. For shelf life after mixing, see how long reconstituted peptides last. Use the reconstitution calculator to determine exactly how much bacteriostatic water to add for your target concentration.

Reconstitution math is where dosing errors happen. The peptide vial label states milligrams. Your syringe measures in units. You need to translate between the two.

The formula:

Dose in units = (desired dose in mcg / concentration in mcg per mL) x 100

Example: You have a 5mg BPC-157 vial reconstituted with 2mL bacteriostatic water. Concentration = 5000mcg / 2mL = 2500mcg per mL. Your target dose is 250mcg. Units to draw = (250 / 2500) x 100 = 10 units on a 1mL insulin syringe.

Skip the math entirely by entering your vial size, reconstitution volume, and desired dose into the reconstitution calculator. For semaglutide-specific dosing, see the semaglutide dosage chart in mL and the semaglutide dosage calculator. For tirzepatide, use the tirzepatide dosage calculator.

Drawing from the vial:

1. 1.Swab the vial stopper with a fresh alcohol pad. Let it dry.
2. 2.Pull the syringe plunger back to the number of units you want to draw. This fills the barrel with air.
3. 3.Insert the needle through the rubber stopper.
4. 4.Push the air into the vial. This equalizes pressure and prevents a vacuum that makes drawing difficult.
5. 5.Invert the vial so the stopper faces the floor and the needle tip is submerged in liquid.
6. 6.Pull the plunger back slowly to your target number of units.
7. 7.Check for air bubbles. If present, flick the syringe barrel with your fingernail to move bubbles to the top, then push the plunger slightly to expel them. An air bubble displaces peptide solution: a 3-unit bubble in a 10-unit draw means you actually have 7 units of peptide and 3 units of air. That is a 30% underdose.
8. 8.Remove the syringe from the vial. The syringe is now loaded and ready.

Subcutaneous injection places the peptide into the adipose (fat) layer between the skin and the muscle. This is the default route for nearly every research peptide. The fat layer acts as a slow-release depot, absorbing the peptide into the bloodstream over 15 to 30 minutes.

Think of the fat layer like a sponge sitting on top of a muscle. You want the needle tip in the sponge, not in the muscle below it. A 0.5-inch needle inserted at 45 degrees penetrates approximately 8 to 9mm, which lands squarely in the subcutaneous fat for most body types.

Intramuscular (IM) injection places the peptide directly into muscle tissue. Absorption is slightly faster (10 to 20 minutes to peak plasma concentration vs. 15 to 30 for subcutaneous), but the trade-offs make IM the less common route for peptides. It requires a longer, thicker needle, involves a deeper insertion, and carries higher bruising risk.

When IM injection is appropriate: - Deep muscle injuries (hamstring tear, quad strain) where you want the peptide placed as close to the damaged fiber as possible - Large injection volumes (over 1mL) that would create an uncomfortable lump subcutaneously - Specific peptide protocols that call for IM delivery based on research data

For most peptide users injecting BPC-157, GHK-Cu, semaglutide, or tirzepatide, subcutaneous is the correct and easier route. If your protocol does not specifically require IM, skip this section.

Gauge measures needle diameter. Higher numbers mean thinner needles. Thinner needles hurt less but draw liquid more slowly. For water-based peptide solutions, the trade-off is minimal because the liquid is low-viscosity and flows easily even through a 31 gauge needle.

For subcutaneous peptide injection, use 29 or 30 gauge. This is the sweet spot: thin enough for minimal pain, wide enough to draw from the vial without fighting resistance, and short enough (0.5 inch) to stay in the fat layer at 45 degrees. If you inject near bony areas with thin skin overlying the bone (lateral knee, elbow, dorsal wrist), step up to 31 gauge.

Needle selection matters more than you might expect. Arendt-Nielsen et al. demonstrated that a 0.1mm reduction in needle diameter reduced pain perception by approximately 10 to 20% in subcutaneous injection trials (Arendt-Nielsen et al., Eur J Pain, 2006). The difference between a 25 gauge (0.51mm) and a 31 gauge (0.26mm) is nearly half the diameter and a proportional reduction in discomfort.

For specific peptide gauge recommendations, see the GHK-Cu injection dosage guide and the BPC-157 dosage guide for 200lb males.

Injecting in the same spot repeatedly causes lipodystrophy: localized changes in the fat layer that appear as hard lumps (lipohypertrophy) or depressions (lipoatrophy). Lipohypertrophy also impairs peptide absorption. A study of 430 insulin-injecting patients found that 64.4% had lipohypertrophy at preferred injection sites, and those sites showed 25% slower insulin absorption compared to unaffected tissue (Blanco et al., Diabetes Metab, 2013).

The fix is simple: rotate your injection sites on a predictable schedule.

Abdominal rotation (most common for peptides):

Divide your abdomen into 4 quadrants, using the navel as the center point: - Upper left - Upper right - Lower left - Lower right

Inject in one quadrant per day, cycling through all four before returning to the first. Within each quadrant, space each injection at least 1 inch (2.5 cm) from the previous puncture in that quadrant. This gives each site a minimum 4-day rest between injections.

Full-body rotation (for protocols with multiple daily injections or long cycles):

If you inject more than once daily or run cycles lasting 3+ months, rotate across body regions: - Week 1: Abdomen - Week 2: Right thigh - Week 3: Left thigh - Week 4: Right upper arm (if accessible)

This schedule ensures no single area bears excessive puncture load. For protocols involving peptide stacking where you inject 2 or 3 different peptides per day, use a different body region for each peptide rather than clustering all injections in one quadrant.

Injection-site infections are the most preventable complication of self-administered peptide injections. The bacteria that cause infection come from three sources: your skin, the vial stopper, and the environment. Addressing all three reduces infection risk to near zero.

The sterile technique checklist:

Never reuse an insulin syringe. A used needle develops microscopic burrs on the tip after a single pass through a rubber stopper and skin. The second use tears tissue rather than cutting cleanly, increasing pain and creating a larger wound channel for bacteria. Under electron microscopy, a once-used 31 gauge needle shows visible tip deformation (Puñal-Riobóo et al., Diabetes Technol Ther, 2014).

Signs of injection-site infection: Expanding redness beyond 2 cm from the puncture after 48 hours, warmth to the touch, pus or drainage, red streaks radiating outward, fever, or swelling that worsens rather than resolves. Minor redness and a small bump at the injection site within the first 24 hours are normal. If symptoms progress beyond 48 hours, seek medical evaluation. Do not attempt to drain an abscess at home. For a complete safety overview, see the peptide safety guide.

Pain from a correctly performed subcutaneous peptide injection ranges from "felt nothing" to "brief pinch." Most of the discomfort that new injectors experience comes from avoidable technique errors, not from the needle itself.

The 6 variables that control injection pain:

1. 1.Let the vial warm slightly. Cold liquid stings. Remove the vial from the refrigerator 2 to 3 minutes before drawing. Do not warm it in hot water, a microwave, or direct sunlight. Peptides are thermolabile: temperatures above 25 degrees Celsius degrade most compounds. A few minutes at room temperature is sufficient to take the chill off without damaging the peptide.

1. 1.Wait for the alcohol to dry. This is the single most common cause of injection pain. Isopropyl alcohol pushed into subcutaneous tissue by the needle causes a sharp, burning sensation lasting 10 to 20 seconds. Fifteen seconds of air drying after swabbing eliminates this entirely.

1. 1.Inject slowly. Push the plunger over 5 to 10 seconds. Rapid injection creates hydraulic pressure in the tissue, stretching it painfully. For small volumes (under 10 units), 5 seconds is enough.

1. 1.Pinch firmly. A strong pinch between thumb and index finger lifts the fat layer and activates pressure-induced analgesia in the surrounding tissue. A weak pinch leaves the skin taut and makes needle entry more noticeable.

1. 1.Insert quickly. Paradoxically, a swift, dart-like insertion hurts less than a slow, hesitant push. The needle passes through nerve-dense skin layers in a fraction of a second when inserted quickly. Slow insertion prolongs contact with those nerves.

1. 1.Breathe out during insertion. Exhaling relaxes the abdominal wall (and muscles generally). Tense muscles resist the needle. Relaxed tissue yields easily. Physical therapists use this principle during manual procedures.

For the first few injections: Hold an ice cube wrapped in a paper towel against the injection site for 20 to 30 seconds before swabbing. The cold temporarily numbs the skin. Most users stop doing this after the first week once they realize how little the injection actually hurts.

For injection-site reaction management specific to tirzepatide, see tirzepatide injection site reactions. For frequency guidelines, see how often to inject GHK-Cu.

Every used syringe, needle, and lancet is classified as a "sharp" and must be disposed of in a puncture-resistant container. Tossing needles into household trash exposes waste handlers, family members, and pets to needlestick injuries and potential bloodborne pathogen transmission.

Acceptable sharps containers: - FDA-cleared sharps disposal containers (red, rigid plastic, available at pharmacies for $5 to $15) - A heavy-duty plastic household container (empty laundry detergent bottle, thick plastic jar) with a screw-on lid, labeled "SHARPS: DO NOT RECYCLE"

Never put sharps in: - Thin plastic bags or grocery bags - Glass containers (breakable) - Aluminum cans (sharp edges, crushable) - Any container that a child could open

When the container is three-quarters full, seal it. Do not compress or overfill. Your disposal options vary by location:

Check your state and local regulations. Some US states (California, New York, New Jersey, among others) have specific sharps disposal laws. The FDA provides a state-by-state guide at fda.gov/sharps.

Never recap a used needle. This is worth repeating. Recapping is the leading cause of accidental needlestick injury. Place the entire syringe, needle attached, directly into the sharps container after each injection.

Proper storage between injections determines whether your peptide retains full potency for 28 to 30 days or degrades into an expensive vial of inert liquid.

Storage rules for reconstituted peptides:

Practical tips: - Designate one shelf in the refrigerator for peptide vials. Keep them away from the freezer vent and the back wall where temperatures can dip below 2 degrees Celsius. - Write the reconstitution date on each vial with a permanent marker. When you reach day 28, discard the remaining solution regardless of how much is left. - If the solution turns cloudy, develops visible particles, or changes color, discard immediately. Turbidity indicates protein aggregation or microbial contamination.

For a complete storage guide covering lyophilized and reconstituted peptides, temperature excursions, and travel considerations, see how to store peptides. For bacteriostatic water storage requirements, see how much bacteriostatic water for semaglutide.

Every mistake on this list has been made by thousands of first-time injectors. None of them are dangerous if identified and corrected. The danger comes from repeating them.

The air bubble question: Small air bubbles (1 to 2 units) injected subcutaneously are not medically dangerous. The air is absorbed by surrounding tissue within minutes. The problem is dosing accuracy, not safety. A 3-unit air bubble in a 10-unit dose means you received 7 units of peptide instead of 10. That is a 30% underdose. Always eliminate bubbles before injecting.

For additional troubleshooting specific to individual peptides, see how to take BPC-157 and the FDA peptide crackdown 2026 for regulatory considerations affecting peptide sourcing and supply.